Ceramide metabolism plays a critical role in cancer development and progression, making it a promising target for cancer therapy. Ceramides, as signaling molecules, regulate apoptosis, cell proliferation, and metabolism, acting as tumor suppressors by inhibiting cell survival pathways and activating apoptotic mechanisms. Strategies to modulate ceramide levels in cancer cells include using synthetic analogs, inhibiting ceramide degradation, and activating ceramide synthesis. Combination therapies with chemotherapies, immunotherapies, and anti-angiogenics have shown synergistic antitumor effects. Ongoing clinical trials are evaluating ceramide nanoliposomes and analogs for their therapeutic potential. However, challenges such as the complexity of ceramide metabolism, targeted delivery, cancer heterogeneity, resistance mechanisms, and long-term safety must be addressed to optimize the efficacy and safety of ceramide-based therapies. Despite these challenges, ceramide-based therapy holds promise for cancer treatment, with ongoing research aimed at overcoming these hurdles and advancing its clinical application. The review highlights the importance of understanding ceramide biology to develop novel cancer treatments and improve clinical outcomes.Ceramide metabolism plays a critical role in cancer development and progression, making it a promising target for cancer therapy. Ceramides, as signaling molecules, regulate apoptosis, cell proliferation, and metabolism, acting as tumor suppressors by inhibiting cell survival pathways and activating apoptotic mechanisms. Strategies to modulate ceramide levels in cancer cells include using synthetic analogs, inhibiting ceramide degradation, and activating ceramide synthesis. Combination therapies with chemotherapies, immunotherapies, and anti-angiogenics have shown synergistic antitumor effects. Ongoing clinical trials are evaluating ceramide nanoliposomes and analogs for their therapeutic potential. However, challenges such as the complexity of ceramide metabolism, targeted delivery, cancer heterogeneity, resistance mechanisms, and long-term safety must be addressed to optimize the efficacy and safety of ceramide-based therapies. Despite these challenges, ceramide-based therapy holds promise for cancer treatment, with ongoing research aimed at overcoming these hurdles and advancing its clinical application. The review highlights the importance of understanding ceramide biology to develop novel cancer treatments and improve clinical outcomes.